Summary
45 / 100 · Bulios Score
What speaks for it
- It has been profitable 6 years in a row.
What to watch
- Earnings per share fell by 46% a year over the last 3 years.
- It pays out more in dividends than it earns: 563% of profit.
- The share price is above the Bulios Fair Price.
- Out of every 100 ZAR of revenue, only 2.8 ZAR is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 64.5 ZAR for 1 ZAR of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (ZAR)
Diluted EPS (ZAR)
- Analyst estimate
Revenue fell by 4.9% a year over 5 years. Over the last 3 years it grew by 2.0% a year. Earnings per share fell by 46% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 ZAR of revenue goes
- Cost of sales 75 ZAR
- Sales and administration 18 ZAR
- Taxes and other 4.7 ZAR
- Net profit 2.5 ZAR
Net profit, industry median (Asset Management) 34 ZAR
Out of every 100 ZAR of revenue, 2.5 ZAR is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 8.74%
- Paid out of profit
- 563%
You receive $0.10 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 1
- Sell 0
No analyst has published a price target.
0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.